Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
According to PubMed, bel and Csobod Csajbkn (2026) synthesised evidence showing depot-specific effects on visceral versus subcutaneous fat, regulation of adipocyte lipolysis, enhancement of mitochondrial biogenesis, induction of beige adipocyte programming, modulation of adipokine secretion, and attenuation of fibrosis (DOI)
Am J Clin Nutr, 2009
Consider your medical history BMI and Comorbidities: GLP-1 agonists: Weight loss medications are an approved treatment for people with a Body Mass Index (BMI) over 30, or a BMI over 27 with at least one comorbidity like type 2 diabetes, hypertension or sleep apnea
Customizable Formulations Compounded peptide therapy allows healthcare providers to prescribe custom concentrations and combinations, supporting personalized treatment protocols that can be adjusted based on the patient's response
US$ 26.19
US$ 22.75
US$ 21.99
US$ 26.49
